ADAGIO-LIPIDS: Rimonabant Reduces Visceral Fat and Improves Lipid ParametersA new rimonabant study presented this week showed that the drug improved lipid parameters, but more important, reduced visceral adipose tissue, the type of abdominal obesity that contributes to big waistlines and type 2 diabetes.
Imaging Studies Won't Trump Clinical End Points but Can Aid Drug-Development DecisionsDrs John Kastelein and Juan Badimon gathered to debate whether or not imaging studies could substitute for clinical end-point trials, but almost from the beginning the two experts agreed that imaging is not there just yet. However, the technology is improving, and existing technologies still can aid in drug-development decisions, they say.
PREDICT: Calcium Screening for Diabetic Patients to Further Stratify Risk of Cardiovascular Events?Coronary artery calcification is associated with cardiovascular events in patients with type 2 diabetes, was a stronger independent predictor than many risk factors, and appears to add significantly to existing risk scores, such as the Framingham and the UKPDS risk scores, according to a new study.
Heartwire, April 28, 2008
Legal Disclaimer
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the European Atherosclerosis Society. These materials and the related activity are not sanctioned by the European Atherosclerosis Society or the commercial supporter of the conference and do not constitute an official part of that conference.
